These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.   

investors@repligen.com

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
2/22/2017
7:30 AM ET
Earnings Release

Repligen Reports Fourth Quarter 2016 Financial Results, Provides Guidance for 2017

2/22/2017

Fourth quarter 2016 revenue of $25.6 million reflects 19% growthFull year 2016 revenue of $104.5 reflects 25% growthFull year 2016 GAAP and adjusted operating income grew 16% and 20% respectively
 Continue Reading

2/16/2017
5:02 PM ET
Press Release

Repligen To Report Fourth Quarter and Full Year 2016 Financial Results, Provides Financial Guidance for 2017

2/16/2017

WALTHAM, Mass., Feb. 16, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report fourth quarter and full year 2016 financial results on Wednesday, Fe...

 Continue Reading
1/4/2017
7:30 AM ET
Press Release

Repligen to Present at 35th Annual J.P. Morgan Healthcare Conference

1/4/2017

WALTHAM, Mass., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at...

 Continue Reading
12/15/2016
7:41 AM ET
Press Release

UPDATE -- Repligen Acquires TangenX Technology Corporation

12/15/2016

WALTHAM, Mass., Dec. 15, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has acquired Tan...

 Continue Reading
11/7/2016
11:27 AM ET
Press Release

Repligen to Participate in Stephens Inc. Fall Investment Conference 2016

11/7/2016

WALTHAM, Mass., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a leading innovator and provider of high-value products to improve the process of manufacturing biologic drugs,...

 Continue Reading
Displaying 1 to 5 (of 190 releases)